MOTS-c is a 16-amino-acid peptide with an unusual origin: it is encoded not in the nuclear genome but in mitochondrial DNA. Since its description in 2015, it has become one of the most closely studied members of the mitochondrial-derived peptide (MDP) family, a group of small signaling molecules that researchers use to probe how mitochondria communicate with the rest of the cell. This article reviews the published mechanism and pathway research on MOTS-c, the main open questions, and what laboratories should document when they include it in a non-clinical study.
RUO notice: MOTS-c and every compound mentioned here are discussed only in the context of laboratory and preclinical research. Nothing in this article describes or supports use in people or animals.
What Makes MOTS-c Different
Most peptides studied in signaling research are cut from larger precursor proteins encoded in the nucleus. MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is instead encoded by a short open reading frame (sORF) inside the mitochondrial 12S ribosomal RNA gene, MT-RNR1 (Lee et al., 2015).
That origin matters for experimental design. The mitochondrial genome is small, maternally inherited and present in many copies per cell, and it was long assumed to code only for a handful of proteins, ribosomal RNAs and transfer RNAs. The discovery of functional peptides in sORFs, first humanin and later MOTS-c, opened a new research question: does the mitochondrion send its own encoded signals to the nucleus and to distant tissues?
The Mitochondrial-Derived Peptide Family
MOTS-c is studied alongside related peptides, and many papers compare them directly. A 2020 review counted eight MDPs identified to date: MOTS-c from the 12S rRNA gene, and humanin plus small humanin-like peptides 1–6 (SHLP1–6) from the 16S rRNA gene (Merry et al., 2020).
| Peptide | Mitochondrial gene region | Main research themes |
|---|---|---|
| MOTS-c | 12S rRNA (MT-RNR1) | Folate cycle, AMPK signaling, nuclear gene regulation, skeletal muscle metabolism |
| Humanin | 16S rRNA (MT-RNR2) | Cytoprotection, apoptosis, neurobiology models |
| SHLP1–6 | 16S rRNA (MT-RNR2) | Cell viability, apoptosis, insulin-sensitivity models |
The SHLPs were characterized through an in silico search of the same 16S region that encodes humanin. In cell culture, SHLP2 and SHLP3 reduced apoptosis and reactive oxygen species, and circulating SHLP2 levels were reported to decline with age (Cobb et al., 2016). Comparing peptides across this family helps researchers separate effects that are specific to MOTS-c from broader MDP signaling.
For a wider view of how mitochondrial pathways fit into aging biology research, see our guide to longevity and cellular aging research with peptides.
Mechanism 1: The Folate Cycle, AICAR and AMPK
The founding MOTS-c study proposed a metabolic mechanism that is still the backbone of the field. In cell models, MOTS-c inhibited the folate cycle and the de novo purine biosynthesis pathway tethered to it, which led to activation of AMP-activated protein kinase (AMPK) (Lee et al., 2015). Skeletal muscle appeared to be its primary target tissue.
The proposed chain of events is:
- MOTS-c disrupts the folate–methionine cycle.
- De novo purine synthesis is interrupted, and the intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) accumulates.
- AICAR acts as an AMP mimetic and activates AMPK, a central sensor of cellular energy status.
A later review summarized the field the same way, describing AICAR–AMPK activation through folate–methionine cycle disruption as the main route, with downstream changes reported in genes such as GLUT4, STAT3 and IL-10 (Gao et al., 2023).
In mouse models, the original study reported that MOTS-c exposure was associated with reduced age-dependent and high-fat-diet-induced insulin resistance and weight gain (Lee et al., 2015). These are animal findings that describe a pathway. They are not evidence of any effect in people.
Because this mechanism runs through one-carbon metabolism and cellular energy sensing, MOTS-c research often sits next to studies of related metabolic pathways, including NAD+ biology (NAD+ 500mg, NAD+ 1000mg) and nicotinamide N-methyltransferase (NNMT) biology, where the small-molecule research compound 5-Amino-1MQ is used as a tool.
Mechanism 2: Mitonuclear Signaling
The second major finding moved MOTS-c from a metabolic modulator to a candidate retrograde signal. Under metabolic stress such as glucose restriction, MOTS-c translocated from the cytoplasm into the nucleus in an AMPK-dependent manner (Kim et al., 2018).
Once in the nucleus, MOTS-c regulated a broad set of genes, including genes with antioxidant response elements (AREs). It also interacted with stress-responsive transcription factors that regulate AREs, such as NFE2L2 (NRF2). The authors argued that the mitochondrial and nuclear genomes co-evolved to encode factors that regulate each other.
For lab teams, this creates useful experimental readouts:
- Subcellular localization (cytoplasmic versus nuclear fractions, imaging)
- AMPK phosphorylation status as a gate for translocation
- ARE-driven reporter activity and NRF2 target gene expression
- Transcriptome changes under nutrient-replete versus nutrient-restricted conditions
Mechanism 3: Exercise, Muscle and Aging Models
A 2021 study tied MOTS-c to skeletal muscle physiology and age-related decline in mice. MOTS-c exposure was associated with higher physical-performance measures in young (2-month), middle-aged (12-month) and old (22-month) mice, and late-life exposure was associated with higher physical-capacity and healthspan measures in the animals (Reynolds et al., 2021).
The same paper reported that MOTS-c regulated nuclear genes related to metabolism and proteostasis and supported myoblast adaptation to metabolic stress. In a separate observational component, exercise raised endogenous MOTS-c levels in human skeletal muscle and circulation. That observation concerns the body's own MOTS-c in response to exercise, not the effect of any supplied compound.
These results are why MOTS-c appears in muscle-metabolism and aging-model research. They should not be read as human performance or anti-aging claims.
Genetic Evidence: The m.1382A>C Variant
Human genetic data add a different kind of evidence. An Asian-specific mtDNA variant, m.1382A>C (rs111033358), causes a K14Q amino acid change in MOTS-c (Zempo et al., 2021). A meta-analysis of three cohorts (n = 27,527) found that males, but not females, carrying the C-allele had a higher prevalence of type 2 diabetes, with the effect concentrated in the least physically active group.
In mouse and cell experiments from the same study, the K14Q form showed reduced insulin-sensitizing activity compared with the native sequence. For researchers, this variant is a useful tool: the K14Q analog can serve as a structure–function comparator, and it shows how a single residue change can alter MOTS-c activity.
Open Questions in the Field
MOTS-c research is still young, and several questions remain open:
- Receptor and uptake. How MOTS-c enters cells, and whether a specific receptor or transporter is involved, is not fully defined.
- Translation site. Because the sORF sits in mitochondrial DNA, researchers debate whether the peptide is translated inside mitochondria or in the cytoplasm, which uses a different genetic code.
- Measurement. Circulating MDP levels are reported to vary with obesity, diabetes and age (Merry et al., 2020), but assay methods differ between labs, which makes cross-study comparison hard.
- Translation to people. The review literature itself notes that it remains to be determined whether MDP biology can be harnessed for any clinical purpose (Merry et al., 2020).
Documentation and Quality Considerations
Small peptides can be sensitive to sequence errors, truncations and oxidation, and a 16-residue sequence with a single-residue variant (K14Q) shows how much one position can matter. Before including MOTS-c in a study, labs should confirm:
- Identity. Mass spectrometry confirming the expected molecular weight for the native sequence.
- Purity. HPLC purity on the certificate of analysis (COA), with the chromatogram available.
- Lot traceability. A batch or lot number on the vial that matches the COA.
- Independent testing. Whether testing was done by an accredited third-party laboratory. Our guide to third-party testing standards explains what to look for.
Stability also affects results in multi-week experiments. Follow the storage conditions on the MOTS-c product page for the specific lot, and see our peptide stability testing protocol for how labs design stability checks. For the regulatory framing of research-use-only compounds, see Understanding Research-Use-Only (RUO) Peptides in 2026.
Summary
MOTS-c is a mitochondrial-encoded peptide studied for its roles in the folate cycle, AICAR–AMPK signaling, stress-induced nuclear gene regulation and skeletal muscle metabolism in preclinical models. Human genetic data on the K14Q variant support the idea that the native sequence is biologically active, while major questions about uptake, translation and measurement remain. Careful identity, purity and lot documentation is essential for reproducible work with this compound.
Related Reading
- Longevity & Cellular Aging Research with Peptides
- Bioregulator Peptides: Epitalon and Thymalin Research
- Third-Party Testing: Industry Standards and Best Practices
- Peptide Stability Testing Protocol
- Understanding Research-Use-Only (RUO) Peptides in 2026
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009
- Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metab. 2018;28(3):516-524.e7. doi:10.1016/j.cmet.2018.06.008
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. doi:10.1038/s41467-020-20790-0
- Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016;8(4):796-809. doi:10.18632/aging.100943
- Merry TL, Chan A, Woodhead JST, et al. Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab. 2020;319(4):E659-E666. doi:10.1152/ajpendo.00249.2020
- Zempo H, Kim SJ, Fuku N, et al. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c. Aging (Albany NY). 2021;13(2):1692-1717. doi:10.18632/aging.202529
- Gao Y, Wei X, Wei P, et al. MOTS-c functionally prevents metabolic disorders. Metabolites. 2023;13(1):125. doi:10.3390/metabo13010125
All products are for laboratory research use only. Not for human or animal consumption.
